BioDExSA PRO LLCThuwal · Kingdom of Saudi Arabia

PioneeringDiagnostic Localizationin Saudi Arabia

Securing the Kingdom's Biosecurity

Scroll

01Introduction

Welcome to BioDExSA PRO

BioDExSA PRO LLC is a premier biotechnology early mover in the Kingdom of Saudi Arabia, founded by Dr. Faris Altaf.

We are strategically positioned to lead the domestic localization, development, and high-standard manufacturing of advanced diagnostic kits. By bridging the gap between global innovations and national infrastructure, we serve the clinical, industrial, and public health sectors with unmatched reliability.

FounderDr. Faris Altaf
  • ClinicalDiagnostics for human health
  • IndustrialAssays for regulated supply chains
  • Public HealthNational surveillance capability

02The Meaning Behind Our Name

Our name is our blueprint

Five deliberate parts. Each one commits us to a discipline — and together they describe exactly how diagnostic capability is built inside the Kingdom.

Bio

Biotechnology

Represents Biotechnology — the scientific foundation on which we build native diagnostic capabilities.

DE

Developing

Stands for Developing — actively engineering biotech solutions from the ground up in Saudi Arabia.

Ex

Exchange

Reflects the Exchange of know-how from global diagnostic leaders into the Saudi market.

SA

Saudi Arabia

Signals our identity as a Saudi company, under scientific and R&D leadership specifically tailored for the Kingdom.

PRO

Professional

Represents professional partners reaching out to build trusted connections, connect expertise and technology, and establish high-standard collaborations that enable technology transfer and sustainable localization.

BioDExSA PRO

Five disciplines, one continuous commitment — from the science at our core to the standard we hold ourselves to.

03Strategic Localization

Saudi Capability.Global Standards.

Localization is not relocation. It is the deliberate transfer of scientific know-how into domestic hands — until the capability to design, validate and manufacture a diagnostic lives entirely within the Kingdom.

  1. Localization

    Bringing the full diagnostic value chain — design, assembly, quality control — onto Saudi ground.

  2. Knowledge Transfer

    Structured exchange with global diagnostic leaders, so expertise stays after the technology arrives.

  3. Scientific Capability

    Building the specialist depth that lets Saudi teams lead development rather than follow it.

  4. Diagnostic Sovereignty

    The ability to detect what matters to the Kingdom without depending on external supply.

  5. Advanced Manufacturing

    High-standard production disciplines applied to diagnostic kits built for local conditions.

  6. Resilient Supply Chains

    Domestic laboratory networks that hold under pressure, not only under normal conditions.

  7. Research & Development

    Continuous R&D leadership tailored to the pathogens, populations and priorities of the Kingdom.

04National Biosecurity

Securing the Kingdom's Biosecurity

National resilience requires self-reliance. BioDExSA PRO explicitly aims to fortify Saudi Arabia's defense against biological threats by supplying locally manufactured diagnostic solutions across four critical sectors:

Diagram: four diagnostic sectors — human health, food safety, animal health and environmental monitoring — connected to a single national biosecurity ecosystem.

Human Health

Rapid and precise infectious disease screening.

Food Safety

Assays designed to safeguard the local supply chain.

Animal Health

Veterinary diagnostics to support livestock and agricultural security.

Environmental Monitoring

Systems tracking ecological health and pathogen variants.

BiosecurityOne ecosystem

05Our Method

From Science to Sovereign Capability

A diagnostic does not become national capability at the moment it is invented. It becomes national capability at the end of a disciplined sequence.

  1. Research

    Scientific groundwork defines what the Kingdom actually needs to detect.

  2. Technology Exchange

    Know-how moves from global diagnostic leaders into Saudi teams.

  3. Localization

    The method is rebuilt for domestic conditions, materials and networks.

  4. Validation

    Performance is proven against the standards clinical use demands.

  5. Manufacturing

    High-standard domestic production turns a validated method into supply.

  6. Deployment

    Kits reach clinical, industrial and public health sectors across the Kingdom.

06National Ambition

Built for a More Resilient Kingdom

A nation that can diagnose itself can defend itself. Every assay developed and manufactured on Saudi ground shortens the distance between a biological threat and the Kingdom's response to it.

That is the work: converting global scientific innovation into capability that stays — held by Saudi laboratories, Saudi manufacturing and Saudi scientists.

  • Self-reliance

    Capability held domestically, not imported under pressure.

  • Readiness

    Detection capacity that exists before it is needed.

  • Continuity

    Supply that does not depend on external conditions.

Partnership

Building Saudi Arabia's Diagnostic Future.

Transforming global scientific innovation into resilient national capability.